Security readout for executives and security teams
Plain-English summary
This issue lets a remote attacker inject script or HTML into affected B. Braun components, but a user must interact with the malicious content. In healthcare or operational environments, that could expose sensitive information and cause limited integrity or availability impact. The provided sources do not show confirmed active exploitation.
Executive priority
Treat this as a high-priority medical technology exposure review, especially if affected components are reachable beyond tightly managed networks. It is not described as actively exploited, but the confidentiality impact and low attack complexity justify prompt inventory, segmentation checks, and vendor-guided remediation.
Technical view
CVE-2020-25158 is reflected XSS in B. Braun SpaceCom L81/U61 and earlier, Battery Pack SP with Wi-Fi, and Data module compactplus A10/A11. CVSS 3.1 is 7.6: network reachable, low complexity, no privileges, user interaction required, with high confidentiality impact and low integrity and availability impact.
Likely exposure
Exposure is most likely where affected B. Braun components are deployed and reachable by users or networks that an attacker can influence. Internet exposure, flat clinical networks, or shared workstations would raise practical risk. The bundle does not provide deployment prevalence or exact CPE matching.
Exploitation context
The CVE is not listed as KEV in the supplied bundle, and no cited source confirms active exploitation. Successful abuse requires user interaction, consistent with reflected XSS. The main concern is unauthorized script execution in a trusted product context, not unauthenticated device takeover.
Researcher notes
Evidence is sufficient for vulnerability type, affected product families, and CVSS characteristics. It is incomplete for exact Battery Pack SP versions, patch availability, and exploit activity. Avoid assuming exploitation or device-control impact beyond reflected XSS without advisory details or environment-specific validation.
Mitigation direction
- Check B. Braun and CISA advisories for supported fixes or compensating controls.
- Inventory affected SpaceCom, Battery Pack SP with Wi-Fi, and Data module compactplus deployments.
- Restrict access to affected management or web interfaces to trusted networks only.
- Reduce exposure from shared workstations and untrusted links in clinical environments.
- Monitor vendor guidance before applying device changes in patient-care environments.
Validation and detection
- Confirm product model and firmware or software version against the affected list.
- Verify whether affected interfaces are reachable from user, guest, or external networks.
- Review logs or proxy records for suspicious reflected-script patterns, without replaying payloads.
- Confirm remediation status against current B. Braun guidance.
- Document residual exposure where devices cannot be updated immediately.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-79: User-session and phishing behavior lookup
Client-side and session-facing weaknesses should be reviewed alongside initial-access and user-execution behaviors. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupCVE-2020-25158 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- High
- CVSS
- 7.6 (3.1)
- Known Exploited
- No
- Published
Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:L/A:L
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS vector scores
1 official scoreWe collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:L/A:L2.84.7Primary CVE scoreVulnerability scoring details
Base CVSS 3.1 score
7.6HighVector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:L/A:L
Source materials
- CVE List V5 sourceCVE List V5
- https://www.cisa.gov/uscert/ics/advisories/icsma-20-296-02CVE reference · x_refsource_CONFIRM
- https://www.bbraun.com/en/products-and-therapies/services/b-braun-vulnerability-disclosure-policy/security-advisory.htmlCVE reference · x_refsource_CONFIRM
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.